Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical

Read MoreHide Full Article

For Immediate Release

Chicago, IL – July 24, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (JNJ - Free Report) , Nike (NKE - Free Report) , Schlumberger (SLB - Free Report) , CSX (CSX - Free Report) and Intuitive Surgical (ISRG - Free Report) .

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Monday’s Analyst Blog:

Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Nike and Schlumberger. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Johnson & Johnson’s shares have lost -9.9% year to date, underperforming the -1.2% decline of the Zacks Large Cap Pharmaceuticals industry. J&J beat estimates for both earnings and sales in Q2 and raised its organic growth outlook for the year. J&J’s sales growth has accelerated since the second half of 2017 backed by higher sales in the Pharmaceutical segment and improving performance in Medical Devices segment.

Though quite a few key products in J&J’s portfolio are facing generic competition, the Zacks analyst thinks new products in all segments, successful label expansion of cancer drugs like Imbruvica and Darzalex and contribution from recent acquisitions will continue to drive top-line growth. J&J is also making rapid progress with its pipeline and line extensions.

Meanwhile, share buybacks and restructuring initiatives should provide bottom-line support. Headwinds like generics, pricing pressure, sluggish growth in the Consumer segment and soft global market conditions remain.

(You can read the full research report on Johnson & Johnson here >>>).

Shares of Nike have outperformed the Zacks Shoes and Retail Apparel industry year to date (+23% vs. +18.7%), driven by a strong earnings trend stemming from the solid execution of Consumer Direct Offense. NIKE has delivered positive earnings for over three years now, with fourth-quarter fiscal 2018 marking the 24th straight quarter of earnings beat. Moreover, sales topped estimates for the fifth straight quarter.

Strong progress on Consumer Direct Offense through innovation and focus on direct-to-customer are the key drivers. Additionally, continued growth at international and NIKE Direct businesses, as well as the return of the North America business to growth in the fiscal fourth quarter, aided results. Driven by these positives, the company raised its revenue guidance for fiscal 2019.

However, higher SG&A expenses due to increased demand creation expense and operating overheads are likely to remain a drag to the company’s results. Also, intense competition and currency headwinds remain an impediment.

(You can read the full research report on Nike here >>>).

Schlumberger’s shares have outperformed the Zacks Oil and Gas - Field Services industry over the last year, losing -0.5% vs. -6.5%. Schlumberger is the largest oilfield services player in the world with presence in every energy market.

The Zacks analyst thinks that being the leading provider of technology for complex oilfield projects, Schlumberger is better placed than most peers to take up new offshore projects in the shallow water basins. In fact, the company is expecting more exploration and drilling activities to ramp up in the offshore resources, which will meet the growing demand for crude in the world.

The firm reported strong second-quarter 2018 earnings, thanks to rebound in drilling activities in Russia and the North Sea. However, Schlumberger’s rising project startup costs is a concern since the company is starting up many new developments outside North America.

(You can read the full research report on Schlumberger here >>>).

Other noteworthy reports we are featuring today include CSX Corp. and Intuitive Surgical.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.